Evidence map›Paper›PMID 38035002›Full record

SynthesisFrontiers in pharmacology2023

Effectiveness and safety of edoxaban

Mohammed M Alsultan, Abdullah K Alahmari, Mansour A Mahmoud, Ziyad S Almalki, Wafa Alzlaiq, Faisal Alqarni, Fahad Alsultan, Nehad Jaser Ahmed, Ahmed O Alenazi, Lucas Scharf and 1 more

Open access · goldAbstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Mohammed M AlsultanDepartment of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Abdullah K AlahmariDepartment of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Mansour A MahmoudDepartment of Pharmacy Practice, College of Pharmacy, Taibah University, Al-Madinah Al-Munawara, Saudi Arabia.
Ziyad S AlmalkiDepartment of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Wafa AlzlaiqDepartment of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Faisal AlqarniDepartment of Pharmacy, Security Forces Hospital, Riyadh, Saudi Arabia.
Fahad AlsultanCollege of Medicine, King Saud University, Riyadh, Saudi Arabia.
Nehad Jaser AhmedDepartment of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Ahmed O AlenaziPharmaceutical Care Department, Ministry of the National Guard-Health Affairs, Dammam, Saudi Arabia.
Lucas ScharfJames L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, United States.
Jeff Jianfei GuoJames L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, United States.
Prince Sattam Bin Abdulaziz University · SAImam Abdulrahman Bin Faisal University · SAUniversity of Cincinnati Medical Center · USKing Saud bin Abdulaziz University for Health Sciences · SAKing Saud University · SASecurity Forces Hospital · SATaibah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atrial fibrillationDOACsedoxabansafety and effectivenesswarfarin

Identifiers

PMID38035002
PMCPMC10687440
OpenAlexW4388786415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.